![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Yelle Jocelyn Sauvé Gilles Sayasith Khampoune
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.5, Iss.4, 2001-08, pp. : 443-464
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Structure and Function of HIV-1 Integrase
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HIV-1 Integrase Inhibitors: An Emerging Clinical Reality
By Dayam Raveendra Al-Mawsawi Laith Q. Neamati Nouri
Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. :